Merck & Co., Inc. (MRK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Merck is currently undergoing a significant transformation and is well-positioned for future success [3] - The company has 80 Phase III studies underway, indicating a robust late-stage pipeline [3] Strategic Initiatives - Merck is successfully launching the first wave of its next 20 growth drivers [3] - The company is enhancing its growth through business development efforts [3]